A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.

We have studied a family with severe mental retardation characterized by the virtual absence of speech, autism spectrum disorder, epilepsy, late-onset ataxia, weakness and dystonia. Post-mortem examination of two males revealed widespread neuronal loss, with the most striking finding being neuronal and glial tau deposition in a pattern reminiscent of corticobasal degeneration. Electron microscopic examination of isolated tau filaments demonstrated paired helical filaments and ribbon-like structures. Biochemical studies of tau demonstrated a preponderance of 4R tau isoforms. The phenotype was linked to Xq26.3, and further analysis identified an in-frame 9 base pair deletion in the solute carrier family 9, isoform A6 (SLC9A6 gene), which encodes sodium/hydrogen exchanger-6 localized to endosomal vesicles. Sodium/hydrogen exchanger-6 is thought to participate in the targeting of intracellular vesicles and may be involved in recycling synaptic vesicles. The striking tau deposition in our subjects reveals a probable interaction between sodium/proton exchangers and cytoskeletal elements involved in vesicular transport, and raises the possibility that abnormalities of vesicular targeting may play an important role in more common disorders such as Alzheimer's disease and autism spectrum disorders.

[1]  G. Schellenberg,et al.  The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. , 2010, Archives of neurology.

[2]  G. Gilfillan,et al.  Dual degradation mechanisms ensure disposal of NHE6 mutant protein associated with neurological disease. , 2009, Experimental cell research.

[3]  J. Golden,et al.  Neuronal loss in Pelizaeus–Merzbacher disease differs in various mutations of the proteolipid protein 1 , 2009, Acta Neuropathologica.

[4]  G. Binetti,et al.  Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide , 2009, Neurobiology of Disease.

[5]  B. Ghetti,et al.  White Matter Tauopathy With Globular Glial Inclusions: A Distinct Sporadic Frontotemporal Lobar Degeneration , 2008, Journal of neuropathology and experimental neurology.

[6]  A. Singleton,et al.  Novel progranulin mutation: Screening for PGRN mutations in a Portuguese series of FTD/CBS cases , 2008, Movement disorders : official journal of the Movement Disorder Society.

[7]  J. Gécz,et al.  SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. , 2008, American journal of human genetics.

[8]  E. Hol,et al.  Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration , 2007, Cell Death and Differentiation.

[9]  P. Pietrini,et al.  Corticobasal Syndrome Associated With the A9D Progranulin Mutation , 2007, Journal of neuropathology and experimental neurology.

[10]  D. Geschwind,et al.  Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative , 2007, The Lancet Neurology.

[11]  J. Morris,et al.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.

[12]  N. Cairns,et al.  TDP‐43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations , 2007, Journal of neuropathology and experimental neurology.

[13]  A. Andreadis,et al.  Tau exon 6 is regulated by an intricate interplay of trans factors and cis elements, including multiple branch points , 2007, Journal of neurochemistry.

[14]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[15]  J. Hardy,et al.  Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. , 2006, Brain : a journal of neurology.

[16]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[17]  J. Trojanowski,et al.  Unexpected abundance of pathological tau in progressive supranuclear palsy white matter , 2006, Annals of neurology.

[18]  T. Uchihara,et al.  Familial tauopathy mimicking corticobasal degeneration an autopsy study on three siblings , 2006, Journal of the Neurological Sciences.

[19]  H. Ropers.  X-linked mental retardation: many genes for a complex disorder. , 2006, Current opinion in genetics & development.

[20]  J. Trojanowski,et al.  Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex , 2006, Acta Neuropathologica.

[21]  T. Cooper,et al.  Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1. , 2006, Biochimica et biophysica acta.

[22]  K. Huber.  The fragile X–cerebellum connection , 2006, Trends in Neurosciences.

[23]  M. Gorno-Tempini,et al.  Clinical and neuropsychological features of corticobasal degeneration , 2006, Mechanisms of Ageing and Development.

[24]  A. Delacourte,et al.  Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease , 2005, Neurology.

[25]  E. Buratti,et al.  Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene , 2005, Nucleic acids research.

[26]  E. Buratti,et al.  Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. , 2004, American journal of human genetics.

[27]  Sergio Grinstein,et al.  Diversity of the mammalian sodium/proton exchanger SLC9 gene family , 2004, Pflügers Archiv.

[28]  A. Lang.  Corticobasal degeneration: Selected developments , 2003, Movement disorders : official journal of the Movement Disorder Society.

[29]  C. Epstein,et al.  App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome , 2003, The Journal of Neuroscience.

[30]  K. Zerres,et al.  Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia. , 2003, Brain : a journal of neurology.

[31]  N. Philip,et al.  Mutations in the oligophrenin-1 gene (OPHN1) cause X linked congenital cerebellar hypoplasia , 2003, Journal of medical genetics.

[32]  P. Lantos,et al.  Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.

[33]  T. Bird,et al.  Niemann-Pick Disease Type C Yields Possible Clue for Why Cerebellar Neurons Do Not Form Neurofibrillary Tangles , 2002, Neurobiology of Disease.

[34]  J. Trojanowski,et al.  Biochemical Analysis of τ Proteins in Argyrophilic Grain Disease, Alzheimer's Disease, and Pick's Disease: A Comparative Study , 2002 .

[35]  J. Trojanowski,et al.  Sporadic Pick's disease: A tauopathy characterized by a spectrum of pathological τ isoforms in gray and white matter , 2002, Annals of neurology.

[36]  Murray Grossman,et al.  Signature tau neuropathology in gray and white matter of corticobasal degeneration. , 2002, The American journal of pathology.

[37]  J. Trojanowski,et al.  Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam , 2002 .

[38]  T. Beach,et al.  Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy , 2001, Acta Neuropathologica.

[39]  P. Lantos,et al.  A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies , 2000, Annals of neurology.

[40]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[41]  P. Lantos,et al.  A Quantitative Study of the Pathological Lesions in the Neocortex and Hippocampus of Twelve Patients with Corticobasal Degeneration , 2000, Experimental Neurology.

[42]  J. Trojanowski,et al.  A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's disease , 2000, Journal of neuroscience research.

[43]  R. Stevenson,et al.  X linked severe mental retardation, craniofacial dysmorphology, epilepsy, ophthalmoplegia, and cerebellar atrophy in a large South African kindred is localised to Xq24-q27 , 1999, Journal of medical genetics.

[44]  H. Willard,et al.  Deletion including the oligophrenin-1 gene associated with enlarged cerebral ventricles, cerebellar hypoplasia, seizures and ataxia , 1999, European Journal of Human Genetics.

[45]  A. Delacourte,et al.  Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 1999, Journal of neurochemistry.

[46]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[47]  D. Ledbetter,et al.  LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. , 1998, Human molecular genetics.

[48]  K. Jellinger,et al.  Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study , 1998, European journal of neurology.

[49]  I. Scheffer,et al.  doublecortin , a Brain-Specific Gene Mutated in Human X-Linked Lissencephaly and Double Cortex Syndrome, Encodes a Putative Signaling Protein , 1998, Cell.

[50]  M. Oda,et al.  Ballooned neurons in corticobasal degeneration and progressive supranuclear palsy , 1997 .

[51]  K. Ikeda.  Basic pathology of corticobasal degeneration , 1997 .

[52]  J. Trojanowski,et al.  Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. , 1996, Journal of neuropathology and experimental neurology.

[53]  R. Defendini,et al.  The neuropathology of chromosome 17‐linked dementia , 1996, Annals of neurology.

[54]  P. Hof,et al.  Specific Pathological Tau Protein Variants Characterize Pick's Disease , 1996, Journal of neuropathology and experimental neurology.

[55]  I. Scheffer,et al.  Periventricular Heterotopia: An X-Linked Dominant Epilepsy Locus Causing Aberrant Cerebral Cortical Development , 1996, Neuron.

[56]  P. Lantos,et al.  Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study , 1996, Journal of the Neurological Sciences.

[57]  J. Trojanowski,et al.  Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau (*) , 1995, The Journal of Biological Chemistry.

[58]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[59]  Golder N Wilson,et al.  MASA syndrome is due to mutations in the neural cell adhesion gene L1CAM , 1994, Nature Genetics.

[60]  R. Stevenson,et al.  X–linked spastic paraplegia (SPG1), MASA syndrome and X–linked hydrocephalus result from mutations in the L1 gene , 1994, Nature Genetics.

[61]  A A Schäffer,et al.  Faster sequential genetic linkage computations. , 1993, American journal of human genetics.

[62]  J. Trojanowski,et al.  The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Goodship,et al.  Centiles for adult head circumference. , 1992, Archives of disease in childhood.

[64]  D. Armstrong,et al.  The neuropathology of the Rett syndrome. , 1992, Brain & development.

[65]  W. Brown,et al.  Analysis of neocortex in three males with the fragile X syndrome. , 1991, American journal of medical genetics.

[66]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[67]  K. Wisniewski,et al.  The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. , 1991, American journal of medical genetics.

[68]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[69]  C. Duyckaerts,et al.  Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging , 1990, Neuroscience Letters.

[70]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[72]  J. Trojanowski,et al.  Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.

[73]  V. Lee,et al.  Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[74]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[75]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[76]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[77]  E. Schopler,et al.  Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS) , 1980, Journal of autism and developmental disorders.

[78]  M. Vandermeeren,et al.  Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes , 2004, Acta Neuropathologica.

[79]  J. Trojanowski,et al.  Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease : a comparative study. , 2002, The American journal of pathology.

[80]  J. Trojanowski,et al.  Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. , 2002, The American journal of pathology.

[81]  D. Armstrong.  Neuropathology of Rett syndrome. , 2002, Mental retardation and developmental disabilities research reviews.

[82]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[83]  L. Hakamies,et al.  [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.

[84]  H. Moser,et al.  Neurodystrophies and neurolipidoses , 1996 .

[85]  H. Wiśniewski,et al.  Pathogenesis of amyloid formation in Alzheimer's disease, Down's syndrome and scrapie. , 1988, Ciba Foundation symposium.

[86]  J. Dymecki,et al.  [Pelizaeus-Merzbacher disease]. , 1973, Neuropatologia polska.

[87]  K. Jellinger,et al.  Pelizacus-Merzbacher disease. Transitional form between classical and co-natal (Seitelberger) type. , 1969, Acta neuropathologica.